CryoBalloon Ablation System

DEVICE3 trials

Sponsors

Medtronic Cardiac Ablation Solutions, Pentax Medical

Conditions

Barrett EsophagusEsophageal CancerSymptomatic Paroxysmal Atrial Fibrillation Without Clinically Significant Heart Diseases

Phase 4

Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation

CompletedNCT01803438

Medtronic Cardiac Ablation SolutionsSymptomatic Paroxysmal Atrial Fibrillation Without Clinically Significant Heart Diseases

Start: 2014-06-30End: 2020-01-20Updated: 2025-02-13

Unknown Phase

Multi-center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System

Active, not recruitingNCT02514525

Pentax MedicalBarrett Esophagus

Start: 2016-03-31End: 2025-12-31Target: 150Updated: 2025-01-13

Clinical Study to Evaluate CryoBalloon™ Ablation System in Patients Undergoing Esophagectomy

CompletedNCT02729727

Pentax MedicalEsophageal Cancer

Start: 2016-03-31End: 2016-06-30Updated: 2022-04-28

Related Papers

The Cost-Effectiveness of First-Line Cryoablation vs First-Line Antiarrhythmic Drugs in Canadian Patients With Paroxysmal Atrial Fibrillation.

2023-11-236 citations

An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare service payer perspective

European Heart Journal2023-11-012 citations

An economic evaluation of first-line cryoballoon ablation vs antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a U.S. Medicare perspective

Heart Rhythm O22023-07-2713 citations

Initial rhythm control with cryoballoon ablation vs drug therapy: Impact on quality of life and symptoms

American Heart Journal2021-09-0813 citations

Impact of initial rhythm control with cryoballoon ablation versus drug therapy on atrial fibrillation recurrence and quality of life: results from the Cryo-FIRST study

EP Europace2021-05-01

Abstract 13915: Cryoballoon Catheter Ablation versus Antiarrhythmic Drug as a First-Line Therapy for Patients With Paroxysmal Atrial Fibrillation: Results of the Cryo-FIRST Study

Circulation2020-11-173 citations

Abstract 13916: Quality of Life Measured in First-line Therapy for Paroxysmal Atrial Fibrillation: A Comparison Between Cryoballoon Catheter Ablation versus Antiarrhythmic Drug Therapy

Circulation2020-11-171 citations

Multifocal Cryoballoon Ablation for Eradication of Barrett's Esophagus-Related Neoplasia: A Prospective Multicenter Clinical Trial

The American Journal of Gastroenterology2020-09-2855 citations